gastric bypass surgery

(redirected from Roux-en-Y gastric bypass)
Also found in: Thesaurus, Medical, Acronyms, Encyclopedia.

gastric bypass surgery

n.
A surgical procedure for treating obesity, in which the upper portion of the stomach is separated from the lower portion and is connected to the small intestine below the duodenum, resulting in smaller stomach capacity and reduced absorption of nutrients and calories.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
References in periodicals archive ?
Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study.
Comparative effectiveness of 3 bariatric surgery procedures: Roux-en-Y gastric bypass, laparoscopic adjustable gastric band, and sleeve gastrectomy.
Pregnancy outcomes after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2008; 4: 39-45.
Holzman, "Gastric adenocarcinoma in patients with Roux-en-Y gastric bypass: a case series," Surgery for Obesity and Related Diseases, vol.
Carrodeguas et al., "Frequency and management of internal hernias after laparoscopic antecolic antegastric Roux-en-Y gastric bypass without division of the small bowel mesentery or closure of mesenteric defects: review of 1400 consecutive cases," Surgery for Obesity and Related Diseases, vol.
Schweitzer, "Laparoscopic antecolic Roux-en-Y gastric bypass with closure of internal defects leads to fewer internal hernias than the retrocolic approach," Surgical Endoscopy, vol.
Hunt said: "This is really the only long-term controlled study of Roux-en-Y gastric bypass outcomes and the results are encouraging.
Material and Methods: Data on patients who underwent laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy with a diagnosis of morbid obesity between January 2012 and June 2014 were retrospectively evaluated.
Roux-en-Y gastric bypass (RYGB) surgery results in clinically important and durable cardiometabolic effects and has become an adjunctive measure in ameliorating adverse health outcomes in obese patients (1).
Roux-en-Y gastric bypass may lead to significant weight loss and improvements in health status, but weight regain is a growing problem in this population and more research into all aspects of weight loss maintenance is needed.
Her history included Roux-en-Y gastric bypass surgery.
In the present study, we retrospectively analyzed blood glucose indexes in patients with T2DM and gastric cancer or simple T2DM underwent gastrectomy using modified Roux-en-Y gastric bypass procedures.